Analysts think RVNC stock price could increase by 203%
Jul 31, 2024, 6:26 AM
77.43%
What does RVNC do
Revance Therapeutics, Inc., a clinical stage biotechnology company based in Nashville, Tennessee, specializes in developing and commercializing novel botulinum toxin products for both aesthetic and therapeutic uses. The company, which went public in 2014, offers products like DAXXIFY for aesthetic improvements and is exploring its use in treating muscle movement disorders such as cervical dystonia and upper limb spasticity.
13 analysts think RVNC stock price will increase by 203.24%. The current median analyst target is $11.22 compared to a current stock price of $3.70. The lowest analysts target is $6.06 and the highest analyst target is $26.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
